Gulrez Fazal

1.2k total citations
16 papers, 810 citations indexed

About

Gulrez Fazal is a scholar working on Hepatology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Gulrez Fazal has authored 16 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 7 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Gulrez Fazal's work include Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (7 papers) and Hepatitis B Virus Studies (5 papers). Gulrez Fazal is often cited by papers focused on Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (7 papers) and Hepatitis B Virus Studies (5 papers). Gulrez Fazal collaborates with scholars based in Canada, Egypt and Germany. Gulrez Fazal's co-authors include Marc‐André Poupart, Sylvie Goulet, Jean Rancourt, Martin Poirier, Murray D. Bailey, Diane Thibeault, Ted Halmos, Dominik Wernic, Montse Llinàs‐Brunet and Steven R. LaPlante and has published in prestigious journals such as Journal of Virology, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Gulrez Fazal

16 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gulrez Fazal Canada 13 371 275 267 256 207 16 810
Ted Halmos Canada 12 451 1.2× 215 0.8× 252 0.9× 202 0.8× 255 1.2× 15 747
Sylvie Goulet Canada 16 510 1.4× 290 1.1× 351 1.3× 292 1.1× 256 1.2× 20 939
Laval Chan Canada 16 427 1.2× 274 1.0× 384 1.4× 284 1.1× 332 1.6× 27 968
Ginette McKercher Canada 14 495 1.3× 288 1.0× 502 1.9× 164 0.6× 196 0.9× 30 982
Marc‐André Poupart Canada 18 550 1.5× 303 1.1× 346 1.3× 391 1.5× 520 2.5× 29 1.3k
Van N. Nguyen United States 12 639 1.7× 498 1.8× 260 1.0× 303 1.2× 219 1.1× 14 1.1k
Makonen Belema United States 13 749 2.0× 558 2.0× 322 1.2× 292 1.1× 280 1.4× 18 1.2k
Jean Gauthier Canada 14 245 0.7× 206 0.7× 194 0.7× 194 0.8× 204 1.0× 31 728
Tsuyoshi Adachi Japan 12 694 1.9× 406 1.5× 305 1.1× 177 0.7× 370 1.8× 20 1.2k
Diane Thibeault Canada 19 698 1.9× 396 1.4× 794 3.0× 145 0.6× 317 1.5× 30 1.4k

Countries citing papers authored by Gulrez Fazal

Since Specialization
Citations

This map shows the geographic impact of Gulrez Fazal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gulrez Fazal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gulrez Fazal more than expected).

Fields of papers citing papers by Gulrez Fazal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gulrez Fazal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gulrez Fazal. The network helps show where Gulrez Fazal may publish in the future.

Co-authorship network of co-authors of Gulrez Fazal

This figure shows the co-authorship network connecting the top 25 collaborators of Gulrez Fazal. A scholar is included among the top collaborators of Gulrez Fazal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gulrez Fazal. Gulrez Fazal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Beaulieu, Pierre L., Gordon T. Bolger, Martin Duplessis, et al.. (2015). Multi-parameter optimization of aza-follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 2: Impact of lipophilicity on promiscuity and in vivo toxicity. Bioorganic & Medicinal Chemistry Letters. 25(5). 1140–1145. 5 indexed citations
2.
Beaulieu, Pierre L., Paul C. Anderson, Richard C. Bethell, et al.. (2014). Discovery of BI 207524, an Indole Diamide NS5B Thumb Pocket 1 Inhibitor with Improved Potency for the Potential Treatment of Chronic Hepatitis C Virus Infection. Journal of Medicinal Chemistry. 57(23). 10130–10143. 10 indexed citations
3.
Stammers, Timothy A., René Coulombe, Jean Rancourt, et al.. (2013). Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(9). 2585–2589. 19 indexed citations
4.
Stammers, Timothy A., René Coulombe, Martin Duplessis, et al.. (2013). Anthranilic acid-based Thumb Pocket 2 HCV NS5B polymerase inhibitors with sub-micromolar potency in the cell-based replicon assay. Bioorganic & Medicinal Chemistry Letters. 23(24). 6879–6885. 15 indexed citations
5.
Beaulieu, Pierre L., René Coulombe, Jianmin Duan, et al.. (2013). Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype. Bioorganic & Medicinal Chemistry Letters. 23(14). 4132–4140. 21 indexed citations
6.
Beaulieu, Pierre L., Michael Bös, Michael G. Cordingley, et al.. (2012). Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV). Journal of Medicinal Chemistry. 55(17). 7650–7666. 36 indexed citations
7.
Liuzzi, Michel, Stephen W. Mason, Mireille Cartier, et al.. (2005). Inhibitors of Respiratory Syncytial Virus Replication Target Cotranscriptional mRNA Guanylylation by Viral RNA-Dependent RNA Polymerase. Journal of Virology. 79(20). 13105–13115. 95 indexed citations
8.
Beaulieu, Pierre L., Michael Bös, Yves Bousquet, et al.. (2004). Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency. Bioorganic & Medicinal Chemistry Letters. 14(4). 967–971. 74 indexed citations
9.
Beaulieu, Pierre L., Michael Bös, Yves Bousquet, et al.. (2003). Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives. Bioorganic & Medicinal Chemistry Letters. 14(1). 119–124. 82 indexed citations
10.
Faucher, Anne‐Marie, Peter W. White, Christian Brochu, et al.. (2003). Discovery of Small-Molecule Inhibitors of the ATPase Activity of Human Papillomavirus E1 Helicase. Journal of Medicinal Chemistry. 47(1). 18–21. 99 indexed citations
11.
Llinàs‐Brunet, Montse, Murray D. Bailey, Gulrez Fazal, et al.. (2000). Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(20). 2267–2270. 78 indexed citations
12.
Simoneau, Bruno, Pierre Lavallée, Paul C. Anderson, et al.. (1999). Discovery of non-peptidic P2–P3 butanediamide renin inhibitors with high oral efficacy. Bioorganic & Medicinal Chemistry. 7(3). 489–508. 27 indexed citations
13.
Poupart, Marc‐André, et al.. (1999). Solid-Phase Synthesis of Peptidyl Trifluoromethyl Ketones. The Journal of Organic Chemistry. 64(4). 1356–1361. 71 indexed citations
14.
Llinàs‐Brunet, Montse, Murray D. Bailey, Gulrez Fazal, et al.. (1998). Peptide-based inhibitors of the hepatitis C virus serine protease. Bioorganic & Medicinal Chemistry Letters. 8(13). 1713–1718. 113 indexed citations
15.
Llinàs‐Brunet, Montse, Murray D. Bailey, Robert Déziel, et al.. (1998). Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease. Bioorganic & Medicinal Chemistry Letters. 8(19). 2719–2724. 60 indexed citations
16.
Fazal, Gulrez, et al.. (1991). A new solid phase strategy for the synthesis of mammalian glucagon. Tetrahedron Letters. 32(5). 577–580. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ted Halmos Breakdown of academic impact, for papers by Sylvie Goulet Breakdown of academic impact, for papers by Laval Chan Breakdown of academic impact, for papers by Ginette McKercher Breakdown of academic impact, for papers by Marc‐André Poupart Breakdown of academic impact, for papers by Van N. Nguyen Breakdown of academic impact, for papers by Makonen Belema Breakdown of academic impact, for papers by Jean Gauthier Breakdown of academic impact, for papers by Tsuyoshi Adachi Breakdown of academic impact, for papers by Diane Thibeault
Rankless by CCL
2026